Corporate Governance

MD Medical is committed to maintaining the highest standards of corporate governance throughout the Group. The Company has an efficient corporate governance framework and internal control on its financial and economic activities that complies with Russian laws, the Rules of the Moscow Exchange, as well as international best practices. Continuous improvement of the corporate governance system is a key long-term strategic priority at MD Medical.

MD Medical Long-Term Corporate Governance Priorities are:

• Safeguard the rights and interests of shareholders and other interested parties
• Information Transparency
• Create an atmosphere of openness, trust and cooperation between the Company, its shareholders, investors, employees, contractors and other interested parties

The Company operates a two tier management structure with a General Shareholders’s Meeting overseeing the Board of Directors.

There are 3 committees under the Board of Directors:

• The Audit Committee
• The Nomination Committee
• The Remuneration Committee

These committees are intended for preliminary consideration of the most important issues and preparation of recommendations for the Board of Directors to take decisions on such issues.

For the purpose of internal audit execution, there is an internal auditor in the Company, who is accountable to the Audit Committee of the Board of Directors.

Effective interaction with shareholders, coordination of the Company’s activities to protect the rights and interests of shareholders, and support for the effective work of the Board of Directors is provided by the Company’s Corporate Secretary.